Dennis E. Saadeh
Corporate Officer/Principal at HARROW, INC.
Network origin in Dennis E. Saadeh first degree
Entity | Entity type | Industry | |
---|---|---|---|
11
| Public Company | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dennis E. Saadeh via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HealthWise of America, Inc.
HealthWise of America, Inc. Managed Health CareHealth Services Part of UnitedHealth Group, Inc., HealthWise of America, Inc. is a health maintenance organization. The company is based in Nashville, TN. HealthWise of America was acquired by UnitedHealth Group, Inc. on April 12, 1996 for $288.70 million. | Managed Health Care | Corporate Officer/Principal | |
Thomas Jefferson University | College/University | Doctorate Degree | |
SGRY LLC
SGRY LLC Hospital/Nursing ManagementHealth Services SGRY LLC provides short-stay surgical facilities. The company was founded in 1999 and is headquartered in Nashville, TN. | Hospital/Nursing Management | Director of Finance/CFO | |
BROOKDALE SENIOR LIVING INC. | Hospital/Nursing Management | Director of Finance/CFO | |
OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Patient Education Concepts, Inc.
Patient Education Concepts, Inc. Medical DistributorsDistribution Services Patient Education Concepts, Inc. provides patient education videos, tools and materials for the ophthalmic industry. It specializes in the production of brochures and other print products and informed consent videos. The company was founded by Robert Watson in 1982 and is headquartered in Houston, TX. | Medical Distributors | Director of Finance/CFO | |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Surgery Center Holdings, Inc.
Surgery Center Holdings, Inc. Finance/Rental/LeasingFinance Surgery Center Holdings, Inc. provides surgical facilities. Its services include physician practices, optical solutions, and laboratory services. The firm focused on developing innovative solutions for physicians and patients. The company is headquartered in Nashville TN. | Finance/Rental/Leasing | Director of Finance/CFO | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Wayne State University (Michigan) | College/University | Undergraduate Degree | |
Vanderbilt University | College/University | Graduate Degree | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Part of Amplifon SpA, Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ is an American company that manufactures and markets hearing aids and related products. Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business was acquired by Amplifon SpA from Bausch & Lomb, Inc. on August 30, 1999. | Medical Specialties | Corporate Officer/Principal | |
Bucknell University | College/University | Undergraduate Degree | |
Trevecca Nazarene University | College/University | Undergraduate Degree | |
University of Detroit Mercy | College/University | Graduate Degree | |
University of Michigan | College/University | Doctorate Degree Doctorate Degree | |
Deloitte & Touche
Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Optuminsight Life Sciences, Inc.
Optuminsight Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Optuminsight Life Sciences, Inc. provides health information technology and consulting services. The company was founded by John E. Ware, James E. Dewey, Al S. Waxman and Ralph J. Perfetto, Jr. in 1997 and is headquartered in Lincoln, RI. | Miscellaneous Commercial Services | Director/Board Member | |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | Chief Executive Officer General Counsel | |
IVERIC BIO, INC. | Pharmaceuticals: Generic | Chairman | |
Symbion Holdings LLC
Symbion Holdings LLC Hospital/Nursing ManagementHealth Services Symbion Holdings LLC owns and operates surgery centers. It offers management and administrative services on a contract basis to surgery centers. The company is headquartered in Nashville, TN. | Hospital/Nursing Management | Director of Finance/CFO | |
Fortera Federal Credit Union
Fortera Federal Credit Union Savings BanksFinance Fortera Federal Credit Union engages in the provision of financial services. It offers personal and business checking and savings accounts, loans, and other banking services. The company was founded in 1954 and is headquartered in Clarksville, TN. | Savings Banks | Corporate Officer/Principal | |
Ingram Content Group LLC
Ingram Content Group LLC Publishing: Books/MagazinesConsumer Services Ingram Content Group LLC publishes and distributes books. It offers solutions that include physical book distribution, print-on-demand, and digital services. The company was founded in 1964 and is headquartered in La Vergne, TN. | Publishing: Books/Magazines | Corporate Officer/Principal | |
Implandata Ophthalmic Products GmbH
Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany. | Electronic Equipment/Instruments | Director/Board Member | |
American Society of Cataract & Refractive Surgery Foundation | Director/Board Member | ||
CELCUITY INC. | Medical Specialties | General Counsel | |
SURGERY PARTNERS, INC. | Hospital/Nursing Management | Director of Finance/CFO | |
EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
ENVISION HEALTHCARE CORPORATION | Medical/Nursing Services | Director of Finance/CFO | |
ETON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
EXICURE, INC. | Biotechnology | General Counsel | |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
Ensemble RCM LLC
Ensemble RCM LLC Miscellaneous Commercial ServicesCommercial Services Ensemble RCM LLC provides revenue cycle management services for hospitals and physician practice operators. It offers full revenue cycle outsourcing, patient access, charge capture and HIM, epic optimization, and physician services. The company was founded by Judson Ivy in 2014 and is headquartered in Huntersville, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Pharmaceuticals: Major | Director/Board Member Founder | |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Retinal Degeneration Fund | Chairman | ||
Radley Pharmaceuticals, Inc.
Radley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Harrow, Inc., Radley Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Carson, NV. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Qlaris Bio, Inc.
Qlaris Bio, Inc. BiotechnologyHealth Technology Qlaris Bio, Inc. operates as a biotechnology company. The company was founded by Thurein Htoo and Barbara Wirostko and is headquartered in Wellesley, MA. | Biotechnology | Director/Board Member | |
TherOptix, Inc.
TherOptix, Inc. Electronic ComponentsElectronic Technology TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA. | Electronic Components | Director/Board Member | |
INNOVAGE HOLDING CORP. | Packaged Software | Director/Board Member | |
ATI PHYSICAL THERAPY, INC. | Medical/Nursing Services | Director/Board Member | |
NVasc, Inc.
NVasc, Inc. Medical SpecialtiesHealth Technology NVasc, Inc. is an early-stage ophthalmology company founded in February 2019 and funded by Kairos Ventures in November 2019. The company is based in Atherton, CA. The company is focused on treating the leading causes of blindness through choroidal and retinal revascularization. The company is planning to manufacture NVB001 that can be used in toxicokinetic studies and in early clinical trials in humans. NVasc has acquired the research rights to growth factors (NVB001 and NVB002) that have been shown to encourage the growth of non-leaking new vessels in the retina and choroid in mouse models of ischemic eye diseases. | Medical Specialties | Director/Board Member | |
Retina Global | Director/Board Member | ||
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Biotechnology | Director/Board Member | |
QualityMetric, Inc. LLC
QualityMetric, Inc. LLC Data Processing ServicesTechnology Services QualityMetric, Inc. LLC is a leading provider of COA solutions and technology-enabled scientific consultancy. The company is based in Johnston, RI, and has subsidiaries in the United States. The company specializes in patient-reported outcome measures and offers a comprehensive suite of scientifically validated PRO surveys, integrated COA technology, and strategic consulting services. QualityMetric helps researchers obtain evidence to make decisions through the use of valid and reliable assessments of functional health and well-being. QualityMetric was founded in 1997, and G. Gus Gardner has been the CEO of the company since 2020. | Data Processing Services | Director/Board Member | |
Corium LLC
Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Biotechnology | Chief Executive Officer |
Statistics
International
United States | 47 |
France | 2 |
Taiwan | 2 |
Germany | 2 |
Sectoral
Health Technology | 18 |
Consumer Services | 10 |
Health Services | 8 |
Commercial Services | 6 |
Finance | 4 |
Operational
Director/Board Member | 65 |
Corporate Officer/Principal | 26 |
Independent Dir/Board Member | 21 |
Founder | 18 |
President | 16 |
Most connected contacts
Insiders | |
---|---|
Adrienne Graves | 38 |
Mark Baum | 36 |
Teresa Sparks | 18 |
Lauren Silvernail | 14 |
Andrew Boll | 10 |
Mark Mannebach | 9 |
Perry Sternberg | 8 |
John Saharek | 6 |
Kim Barratt | 5 |
Marty Makary | 4 |
Jamie Webb | 1 |
- Stock Market
- Insiders
- Dennis E. Saadeh
- Company connections